Rxsight Inc
RXST8.390USD
+0.570+7.29%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
344.67MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Rxsight Inc Unternehmen
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Rxsight Inc Informationen
BörsenkürzelRXST
Name des UnternehmensRxsight Inc
IPO-datumJul 30, 2021
CEOKurtz (Ron M)
Anzahl der mitarbeiter498
WertpapierartOrdinary Share
GeschäftsjahresendeJul 30
Addresse100 Columbia Street
StadtALISO VIEJO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92656
Telefon19495217822
Websitehttps://www.rxsight.com/
BörsenkürzelRXST
IPO-datumJul 30, 2021
CEOKurtz (Ron M)
Führungskräfte von Rxsight Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+188002.00%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
67.06K
+23445.00%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+10752.00%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+10752.00%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-491.00%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+10752.00%
Mr. J. Andy Corley
Mr. J. Andy Corley
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Ron M. Kurtz, M.D.
Dr. Ron M. Kurtz, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+188002.00%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
67.06K
+23445.00%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+10752.00%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+10752.00%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-491.00%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+10752.00%
Umsatzaufteilung
FY2024
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
139.93M
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
5.47%
The Vanguard Group, Inc.
5.42%
Millennium Management LLC
5.33%
Artisan Partners Limited Partnership
5.25%
D. E. Shaw & Co., L.P.
4.46%
Andere
74.06%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
5.47%
The Vanguard Group, Inc.
5.42%
Millennium Management LLC
5.33%
Artisan Partners Limited Partnership
5.25%
D. E. Shaw & Co., L.P.
4.46%
Andere
74.06%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
35.58%
Hedge Fund
24.77%
Investment Advisor/Hedge Fund
13.85%
Research Firm
7.17%
Individual Investor
5.62%
Pension Fund
1.07%
Private Equity
0.68%
Bank and Trust
0.28%
Family Office
0.06%
Andere
10.92%
Institutionelle Beteiligung
Aktualisiert: Mon, Jan 5
Aktualisiert: Mon, Jan 5
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
462
34.25M
83.29%
-14.55M
2025Q3
449
38.67M
94.05%
-9.26M
2025Q2
446
40.83M
100.45%
-3.67M
2025Q1
453
40.49M
99.79%
-7.96M
2024Q4
440
38.96M
96.23%
-5.07M
2024Q3
420
38.15M
94.75%
-3.92M
2024Q2
391
37.00M
93.42%
-2.64M
2024Q1
338
34.63M
93.15%
-2.60M
2023Q4
299
33.17M
91.51%
-284.01K
2023Q3
253
34.41M
96.36%
-1.84M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
2.25M
5.47%
-257.93K
-10.28%
Sep 30, 2025
The Vanguard Group, Inc.
2.15M
5.22%
-123.97K
-5.46%
Sep 30, 2025
Millennium Management LLC
2.19M
5.33%
-417.92K
-16.01%
Sep 30, 2025
Artisan Partners Limited Partnership
1.75M
4.27%
-498.86K
-22.15%
Sep 30, 2025
D. E. Shaw & Co., L.P.
1.83M
4.46%
+512.56K
+38.79%
Sep 30, 2025
NO STREET GP LP
1.63M
3.95%
+425.00K
+35.42%
Sep 30, 2025
Two Sigma Investments, LP
1.39M
3.39%
+770.76K
+123.95%
Sep 30, 2025
Citadel Advisors LLC
1.29M
3.14%
+262.28K
+25.52%
Sep 30, 2025
DWS Investments UK Limited
952.53K
2.32%
-268.84K
-22.01%
Sep 30, 2025
BNP Paribas Securities Corp. North America
903.85K
2.2%
+422.78K
+87.88%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
0.62%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
iShares Morningstar Small-Cap Value ETF
0.01%
iShares Russell 2000 ETF
0.01%
WisdomTree US SmallCap Fund
0.01%
Schwab U.S. Small-Cap ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil0.62%
ProShares Hedge Replication ETF
Anteil0.02%
iShares Russell 2000 Growth ETF
Anteil0.02%
iShares Morningstar Small-Cap Value ETF
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
WisdomTree US SmallCap Fund
Anteil0.01%
Schwab U.S. Small-Cap ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
